Toronto, Washington – The United States Food and Drug Administration (U.S. FDA) today reversed its earlier position on bisphenol A (BPA), now agreeing that the chemical poses ‘some concern’ for the health of fetuses, infants, and young children, particularly on brain development, prostate gland development, and behaviour.
“The U.S. government is following Canada’s lead in recognizing the harmful effects of BPA on our children’s health. It’s a significant change in direction, given that less than two years ago the FDA said BPA posed no health risks,” said Dr. Rick Smith, Executive Director of Environmental Defence. “Canadians should be proud of the leadership our federal government has taken on this issue, including banning BPA in all baby bottles and working to get it out of infant formula cans. Today’s announcement, however, underlines the urgency of going even further.”
Canada set an international precedent in 2008 with the federal government’s proposal to designate BPA as “toxic”, ban it in baby bottles, and set reduction targets on the amount of it that can be found in infant formula. Since then, various U.S. States have passed similar laws, some with even broader bans. However, the FDA has been slow to conclude that the substance is of concern until now.
“This change of position not only vindicates Canada’s earlier decision, but is further evidence of the growing concern regarding BPA’s harmful effects,” said Smith. “Though the Canadian government deserves congratulations for leading the way thus far, it is now time to ban BPA in all food and beverage containers.”
About Environmental Defence (www.environmentaldefence.ca): Environmental Defence protects the environment and human health. We research solutions. We educate. We go to court when we have to. All in order to ensure clean air, clean water and thriving ecosystems nationwide, and to bring a halt to Canada’s contribution to climate change.
-30-
 For more information, or to arrange interviews, please contact:
Jennifer Foulds, Environmental Defence, (416) 323-9521 ext. 232; (647) 280-9521 (cell)